Philips and the Governments of Ethiopia and the Netherlands Sign Seven-Year Agreement to Build Ethiopia's First Specialized Cardiac Care Center

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the governments of Ethiopia and the Netherlands, today signed a seven-year agreement to build Ethiopia's first specialized Cardiac Care Center to address the critical shortage of cardiology services in Ethiopia. Under the terms of the agreement, valued at approximately 40 million euro, Philips will be responsible for the full turnkey design, construction, equipping and commissioning of the hospital location, as well as staff education and equipment maintenance for five years after completion. The new center will be developed within the compound of the existing Tikur Anbessa Specialized Hospital (TASH) in Addis Ababa, the capital city of Ethiopia.

The new specialist cardiac care center will comprise a 7-story building covering 7,200 square meters with three operating rooms, two cath labs, 94 beds, and full diagnostic and examination suites. Scheduled for completion in mid-2020, it is estimated that the new center will have the physical capacity to perform 500 surgeries, 1,600 cath lab diagnoses, and 500 cath lab interventions once operational.

"This is a unique project for Philips globally as we are creating an entire turnkey hospital solution," said Jasper Westerink, CEO of Philips Africa. "Drawing on more than 125 years' of Philips' experience on the African continent, paired with our expertise in holistic healthcare planning and hospital design, we are pleased to support the Government of Ethiopia as a strategic partner in developing and implementing an integrated approach to cardiovascular care that will enable improved treatment and outcomes for patients and clinicians."

The Ethiopian population of over 100 million citizens currently has no access to a continually functioning cardiac center, a bleak reality for a country with one of the highest prevalences of rheumatic heart disease, which is largely preventable and often caused by non-treated throat infections. In Ethiopia, it is the leading cause of acquired heart disease among children and young adults. At Tikur Anbessa Specialized Hospital in Addis Ababa there is a waiting list of over 8,000 patients for cardiac care that currently cannot be addressed.

The agreement not only covers construction of the new cardiac care center, but also renovation of an existing section of the TASH hospital. Renovation of an existing floor in the hospital will begin by June, 2018, and is expected to be completed before the end of the year. It will include installation of a dedicated cardiology operating theatre, a new Philips bi-plane interventional catheterization lab, and a cardiology ICU. This will increase capacity and enable surgical interventions to be performed before the new cardiac care center is ready.

"We want to transform cardiology care in Ethiopia, and in Philips we have a strong partner that understands our requirements and is able to provide a comprehensive hospital solution for state-of-the-art diagnosis and treatment of cardiac diseases, including capability building and skills transfer," said Ato Amir Aman, Minister of Health (MOH) of the Federal Democratic Republic of Ethiopia. "Through this strategic collaboration, TASH will have access to Philips’ health technologies and services, as well as clinical education, IT integration and data analytics, allowing us to fully redesign our care processes for cardiology interventions."

With the aim to improve access to quality healthcare in Africa the Netherlands government is contributing to this project with funding via the Netherlands Enterprise Agency RVO.

Integrated solutions provider

The new specialist cardiology center is another example of Philips’ strategy of delivering co-designed integrated solutions aimed at solving complex healthcare challenges and creating a more sustainable approach to healthcare. These innovative healthcare delivery models help healthcare providers to continuously improve access to care, clinical quality and operational performance, while at the same time enhancing patient and staff experience. Showing great traction across the globe, Philips already has more than one hundred long-term strategic partnerships in the US, Europe, Africa, and Asia.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries.

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

First Virtual DMEA to Open with a Wide R…

16 - 18 June 2020, Berlin, Germany. Under the heading 'DMEA sparks' and taking place for the first time, this year's DMEA is an entirely virtual event. From 16 to 18...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...

Digital Contact Tracing for COVID-19: An…

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help...